C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2011
10/13/2011	CA2795513A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	CA2789818A1 Inverse agonists and neutral antagonists for the tsh receptor
10/12/2011	EP2374798A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374797A1 Benzazepine derivatives useful as vasopressin antagonists
10/12/2011	EP2374795A1 Sulphonic acid derivatives of polycyclic dyes used for analytical applications
10/12/2011	EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic
10/12/2011	EP2373646A1 Phthalazinone and related analogs as sirtuin modulators
10/12/2011	EP2373641A1 Pyridazinone derivatives
10/12/2011	EP2373639A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
10/12/2011	EP2373626A1 Substituted indazole derivatives active as kinase inhibitors
10/12/2011	EP2373609A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
10/12/2011	EP2373172A1 Inhibitors of hcv ns5a
10/12/2011	EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
10/12/2011	EP2176253B1 A process for the preparation or purification of olmesartan medoxomil or olmesartan medoxomil hydrohalide salt
10/12/2011	EP2107052B1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/12/2011	EP2094683B1 Bicyclic compounds and use as antidiabetics
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	CN1934101B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/12/2011	CN1914177B Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/12/2011	CN1849318B Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/12/2011	CN1527809B Process for the preparation of 7-substituted 3-alkyl-3H-isobenzofuran-1-one derivatives
10/12/2011	CN102216293A Preparation of alicyclic diepoxides
10/12/2011	CN102216283A Quinazoline derivatives as NK3 receptor antagonists
10/12/2011	CN102216282A Aryl piperazine and their use as alpha2c antagonists
10/12/2011	CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011	CN102216260A Amino acid derivative
10/12/2011	CN102212065A Isonucleoside compound or ortho-phosphite derivative thereof and preparation method and application thereof
10/12/2011	CN102212062A Derivative of amino ester, salt thereof and using method
10/12/2011	CN102212061A Reducing preparation method for lafutidine
10/12/2011	CN102212060A Method for preparing lafutidine by virtue of aminolysis
10/12/2011	CN102212031A Preparation method of 2-substituted-4-(piperidylmethyl) pyridine
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/12/2011	CN101006177B An improved method for synthesising templated molecules
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2473736C Process for producing dioxolane nucleoside analogues
10/10/2011	CA2793975A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011123678A2 Substituted benzo-pyrido-triazolo-diazepine compounds
10/06/2011	WO2011123536A1 Polycyclic tetracycline compounds
10/06/2011	WO2011122133A1 Material for organic electroluminescence element, and organic electroluminescence element using same
10/06/2011	WO2011122132A1 Material for organic electroluminescence element, and organic electroluminescence element using same
10/06/2011	WO2011121555A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011121505A1 Cytokine inhibitors
10/06/2011	WO2011121309A1 Phenyl sulfonyl derivatives and their use as histamine h3 antagonists
10/06/2011	WO2011080254A3 Fungicide hydroximoyl-heterocycles derivatives
10/06/2011	WO2011045415A3 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/06/2011	WO2010104406A8 Prodrug forms of kinase inhibitors and their use in therapy
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	US20110245500 Melanocortin receptor agonists
10/06/2011	US20110245496 Quinazoline Salt Compounds
10/06/2011	US20110245353 Sweet flavor modifier
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245285 Process for preparation of rosuvastatin acetonide calcium
10/06/2011	US20110245260 Analogs of dehydrophenylahistins and their therapeutic use
10/06/2011	US20110245249 Heterocyclically Substituted Anilinopyrimidines
10/06/2011	US20110245244 Phenoxy acetic acids as ppar delta activators
10/06/2011	US20110245231 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110243844 Sulfonamide derivative metabotropic glutamate r4 ligands
10/06/2011	CA2799727A1 Polycyclic tetracycline compounds
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/06/2011	CA2794676A1 Cytokine inhibitors
10/06/2011	CA2792068A1 Sweet flavor modifier
10/05/2011	EP2371825A1 Process for the synthesis of azacitidine and decitabine
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370416A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
10/05/2011	EP2370414A2 Preparation of capecitabine
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	EP2297118B1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators
10/05/2011	EP1960370B1 Pyridiazinone derivatives for tumour treatment
10/05/2011	EP1958948B1 Pyridazine compound and use thereof
10/05/2011	EP1858520B1 Quinazolinone t-type calcium channel antagonists
10/05/2011	EP1575940B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/05/2011	EP1546136B1 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
10/05/2011	EP1411052B1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof
10/05/2011	CN1938292B Cyclic amine compound and pest control agent
10/05/2011	CN102209719A Novel prostaglandin i2 derivative
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209717A Compounds for the treatment of hepatitis c
10/05/2011	CN102209714A Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
10/05/2011	CN102206208A Preparation method for olmensartan medoxomil with low-level impurity
10/05/2011	CN102206206A Azabicyclooctane hydroximic acid derivatives, preparation method thereof, and application thereof in medicament
10/05/2011	CN101031558B HIV inhibiting 5-heterocyclyl pyrimidines
10/04/2011	US8032873 Computer program code size partitioning system for multiple memory multi-processing systems
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
10/04/2011	US8030339 Imidazole derivatives for the treatment of anxiety and related diseases
10/04/2011	US8030336 Nicotinamide-based kinase inhibitors
10/04/2011	US8030309 Viral polymerase inhibitors

1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 694